• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Cardiovascular Procedure KitTerumo Cardiovascular Systems Corporation

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Cardiovascular Procedure KitTerumo Cardiovascular Systems Corporationsee related information
Date Initiated by FirmJune 08, 2010
Date PostedSeptember 29, 2010
Recall Status1 Terminated 3 on February 29, 2012
Recall NumberZ-2617-2010
Recall Event ID 56413
Product Classification Cardiovascular Procedure Kits - Product Code DTR
ProductCardiovascular Procedure Kit X-Coated H/L pack with Cardioplegia, Item # 70067-03
Code Information Lot Number ME19  
Recalling Firm/
Manufacturer
Terumo Cardiovascular Corporation
125 Blue Ball Road
Elkton MD 21921-5315
For Additional Information ContactMike Silvestri
410-392-7102
Manufacturer Reason
for Recall
Medical device vent port may be occluded and prevent delivery of priming fluid.
FDA Determined
Cause 2
Equipment maintenance
ActionConsignees were contacted on June 8, 2010, by phone, fax, email and priority mail to advise distributors and end-users of the potential occluded vent port defect and provide instructions for the replacement product recall. Consignees were mailed follow-up communications by priority overnight mail on June 9, 2010.
Quantity in Commerce60 kits
DistributionThe products were distributed nationwide.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-